Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Evaluation of Bioresorbable Polymers As Potential Stent Materialin Vivo Degradation Behavior and Histocompatibility

In Vitro Biocompatibility Evaluation of Bioresorbable Copolymers Prepared from L-Lactide, 1, 3-Trimethylene Carbonate, and Glycolide for Cardiovascular Applications

In Vitro Degradation Behavior of L-Lactide/Trimethylene Carbonate/Glycolide Terpolymers and A Composite with Poly(L-Lactide-Co-Glycolide) Fibers

In Vivo Degradation of Copolymers Prepared from L-Lactide, 1,3-Trimethylene Carbonate and Glycolide As Coronary Stent Materials

In Vitro Degradation of Poly[(L‐lactide)‐co‐(trimethylene Carbonate)] Copolymers and a Composite with Poly[(L‐lactide)‐co‐glycolide] Fibers As Cardiovascular Stent Material

Mechanical Properties and Degradation Properties in Vitro of Carbon Fiber Reinforced Hydroxyapatite/polylactide Composite

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Structure, Properties, and in Vitro Degradation Behavior of Biodegradable Poly(l‐lactic Acid)‐trimethylene Carbonate‐glycolide Terpolymer

Totally Bioresorbable Composites Prepared from Poly(l‐lactide)‐co‐(trimethylene Carbonate) Copolymers and Poly(l‐lactide)‐co‐(glycolide) Fibers As Cardiovascular Stent Material

In vitro degradation and biocompatibility evaluation of fully biobased thermoplastic elastomers consisting of poly(β-myrcene) and poly( -lactide) as stent coating

Enzyme-catalyzed Degradation Behavior of L-Lactide/trimethylene Carbonate/glycolide Terpolymers and Their Composites with Poly(l-Lactide-co-glycolide) Fibers

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

[Preliminary Evaluation of the Biological Properties of Poly-Lactide-co-glycolic Acid (PLGA) Knitted Mesh].

Hybrid interpenetrating network of polyester coronary stent with tunable biodegradation and mechanical properties

3D printed peripheral vascular stents based on degradable poly(trimethylene carbonate-b-(L-lactide-ran-glycolide)) terpolymer

Microstructure–property Relationship of L-Lactide/trimethylene Carbonate/glycolide Terpolymers As Cardiovascular Stent Material

In Vivo Degradation Studies of PGA-PLA Block Copolymer and Their Histochemical Analysis for Spinal-Fixing Application

<scp>3D</scp> printed peripheral vascular stents based on degradable poly(<scp>trimethylene carbonate‐b‐(L‐lactide‐ran‐glycolide)</scp>) terpolymer

Biodegradable Poly(trimethylene Carbonate‐b‐(l‐lactide‐ran‐glycolide)) Terpolymers with Tailored Molecular Structure and Advanced Performance

Artificial Coronary Vascular Stents Fabrication Using Biodegradable Material Compounds of PLA/PGA-co-Chitosan

Design and characterization of PLLA stents with Z-structure